(Q47820331)

5 February 2018

title

Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential (English)

1 reference

5 February 2018

0 references

1 reference

Wei Lu

1

1 reference

5 February 2018

Xiao-Dong Wu

2

1 reference

5 February 2018

Mu De Shi

3

1 reference

5 February 2018

Rui Fu Yang

4

1 reference

5 February 2018

You Yu He

5

1 reference

5 February 2018

Chao Bian

6

1 reference

5 February 2018

Tie Liu Shi

7

1 reference

5 February 2018

Sheng Yang

8

1 reference

5 February 2018

Xue-Liang Zhu

9

1 reference

5 February 2018

Wei-Hong Jiang

10

1 reference

5 February 2018

Yi Xue Li

11

1 reference

5 February 2018

Lin-Chen Yan

12

1 reference

5 February 2018

Yong Yong Ji

13

1 reference

5 February 2018

Ying Lin

14

1 reference

5 February 2018

Guo-Mei Lin

15

1 reference

5 February 2018

Lin Tian

16

1 reference

5 February 2018

Jin Wang

17

1 reference

5 February 2018

Hong Xia Wang

18

1 reference

5 February 2018

You Hua Xie

19

1 reference

5 February 2018

Gang Pei

20

1 reference

5 February 2018

Jia Rui Wu

21

1 reference

5 February 2018

Bing Sun

22

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 April 2005

1 reference

5 February 2018

published in

FEBS Letters

1 reference

5 February 2018

volume

579

1 reference

5 February 2018

issue

10

1 reference

5 February 2018

page(s)

2130-2136

1 reference

5 February 2018

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

The Genome sequence of the SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

The SARS-CoV S glycoprotein: expression and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Identification of an epitope of SARS-coronavirus nucleocapsid protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Characterization of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Mosaic evolution of the severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Early diagnosis of SARS coronavirus infection by real time RT-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Assessment of immunoreactive synthetic peptides from the structural proteins of severe acute respiratory syndrome coronavirus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.02.070

Priming and induction of anti-rotavirus antibody response by synthetic peptides derived from VP7 and VP4

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15811330

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A complete sequence and comparative analysis of a SARS-associated virus (Isolate BJ01)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15811330

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.FEBSLET.2005.02.070

1 reference

5 February 2018

1 reference

5 February 2018